Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2705)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2023 (publication date) through Sep 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Peng WT, Jiang C, Yang FL, Zhou NQ, Chen KY, Liu JQ, Peng SF, Fu L. Tenofovir amibufenamide vs tenofovir alafenamide for treating chronic hepatitis B: A real-world study. World J Gastroenterol 2023; 29(44): 5907-5918 [PMID: 38111506 DOI: 10.3748/wjg.v29.i44.5907] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i44/5907.htm |
| Number | Citing Articles |
| 1 |
Qing Zhang, Jianhua Xu, Dan Liu, Lilin Wang, Shan Ren, Sujun Zheng, Xinyue Chen, Li Qi, Junfeng Lu. Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study. Antiviral Therapy 2024; 29(5) doi: 10.1177/13596535241284226
|
| 2 |
Li-Yang Meng, Chao-Ting Yang, Jian-Feng Bao, Jin-Song Huang. Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients. World Journal of Gastroenterology 2024; 30(26): 3261-3263 doi: 10.3748/wjg.v30.i26.3261
|